Xencor, Inc.Xencor, Inc.Xencor, Inc.

Xencor, Inc.

No trades
See on Supercharts

XNCR fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
XNCR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company